Thalidomide-NH-PEG2-C2-NH2 TFA structure
|
Common Name | Thalidomide-NH-PEG2-C2-NH2 TFA | ||
---|---|---|---|---|
CAS Number | 2097509-36-7 | Molecular Weight | 518.44 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H25F3N4O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Thalidomide-NH-PEG2-C2-NH2 TFAThalidomide-O-amido-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1]. |
Name | Thalidomide-NH-PEG2-C2-NH2 TFA |
---|
Description | Thalidomide-O-amido-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C21H25F3N4O8 |
---|---|
Molecular Weight | 518.44 |
Hazard Codes | Xi |
---|